2011 | 2010 |
2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993

1. Harada H, Xie X, Itasaka S, Zeng L, Zhu Y, Morinibu A, Shinomiya K, Hiraoka M.
   Diameter of tumor blood vessels is a good parameter to estimate HIF-1-active regions in solid tumors.
   Biochem Biophys Res Commun, 373: 533-538, 2008.
   PMID: 18586004
2. Isomura M, Oya N, Tachiiri S, Kaneyasu Y, Nishimura Y, Akimoto T, Hareyama M, Sugita T, Mitsuhashi N, Yamashita T, Aoki M, Sai H, Hirokawa Y, Sakata K, Karasawa K, Tomida A, Tsuruo T, Miki Y, Noda T, Hiraoka M.
   IL12RB2 and ABCA1 genes are associated with susceptibility to radiation dermatitis.
   Clin Cancer Res, 14: 6683-6689, 2008.
   PMID: 18927311
3. Kawashita M, Domi S, Saito Y, Aoki M, Ebisawa Y, Kokubo T, Saito T, Takano M, Araki N, Hiraoka M.
   In vitro heat generation by ferrimagnetic maghemite microspheres for hyperthermic treatment of cancer under an alternating magnetic field.
   J Mater Sci Mater Med, 19: 1897-1903, 2008.
   PMID: 17914614
4. Kosaka Y, Mitsumori M, Yamauchi C, Narita Y, Hiraoka M.
   Feasibility of accelerated partial breast irradiation using three-dimensional conformal radiation therapy for Japanese women: a theoretical plan using six patients’ CT data.
   Breast Cancer, 15: 108-114, 2008.
   PMID: 18224404
5. Mitsumori M, Hiraoka M.
   Current status of accelerated partial breast irradiation.
   Breast Cancer, 15: 101-107, 2008.
   PMID: 18224403
6. Naka K, Narita A, Tanaka H, Chujo Y, Morita M, Inubushi T, Nishimura I, Hiruta J, Shibayama H, Koga M, Ishibashi S, Seki J, Kizaka-Kondoh S, Hiraoka M.
   Biomedical applications of imidazolium cation-modified iron oxide nanoparticles
   Polym Adv Technol, 19: 1421-1429, 2008.
7. Nakamura K, Kodaira T, Shikama N, Kagami Y, Ishikura S, Shibata T, Hiraoka M.
   Accelerated fractionation versus conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 Phase III study: Japan Clinical Oncology Group study (JCOG 0701).
   Jpn J Clin Oncol, 38: 387-389, 2008.
   PMID: 18390558
8. Nakamura M, Narita Y, Matsuo Y, Narabayashi M, Nakata M, Yano S, Miyabe Y, Matsugi K, Sawada A, Norihisa Y, Mizowaki T, Nagata Y, Hiraoka M.
   Geometrical differences in target volumes between slow CT and 4D CT imaging in stereotactic body radiotherapy for lung tumors in the upper and middle lobe.
   Med Phys, 35: 4142-4148, 2008.
   PMID: 18841867
9. Nakayama H, Mizowaki T, Narita Y, Kawada N, Takahashi K, Mihara K, Hiraoka M.
   Development of a three-dimensionally movable phantom system for dosimetric verifications.
   Med Phys, 35: 1643-1650, 2008.
   PMID: 18561639
10. Norihisa Y, Nagata Y, Takayama K, Matsuo Y, Sakamoto T, Sakamoto M, Mizowaki T, Yano S, Hiraoka M.
    Stereotactic body radiotherapy for oligometastatic lung tumors.
    Int J Radiat Oncol Biol Phys, 72: 398-403, 2008.
    PMID: 18374506
11. Tanabe K, Hirata N, Harada H, Hiraoka M, Nishimoto S.
    Emission under hypoxia: one-electron reduction and fluorescence characteristics of an indolequinone-coumarin conjugate.
    Chembiochem, 9: 426-432, 2008.
    PMID: 18224643
12. Tanisaka H, Kizaka-Kondoh S, Makino A, Tanaka S, Hiraoka M, Kimura S.
    Near-infrared fluorescent labeled peptosome for application to cancer imaging.
    Bioconjug Chem, 19: 109-117, 2008.
    PMID: 18163535
13. Yamada K, Akiyama N, Yamada S, Tanaka H, Saito S, Hiraoka M, Kizaka-Kondoh S.
    Taip2 is a novel cell death-related gene expressed in the brain during development.
    Biochem Biophys Res Commun, 369: 426-431, 2008.
    PMID: 18291095
14. Zeng L, Ou G, Itasaka S, Harada H, Xie X, Shibuya K, Kizaka-Kondoh S, Morinibu A, Shinomiya K, Hiraoka M.
    TS-1 enhances the effect of radiotherapy by suppressing radiation-induced hypoxia-inducible factor-1 activation and inducing endothelial cell apoptosis.
    Cancer Sci, 99: 2327-2335, 2008.
    PMID: 18823375
15. Zhu SY, Mizowaki T, Norihisa Y, Takayama K, Nagata Y, Hiraoka M.
    Comparisons of the impact of systematic uncertainties in patient setup and prostate motion on doses to the target among different plans for definitive external-beam radiotherapy for prostate cancer.
    Int J Clin Oncol, 13: 54-61, 2008.
    PMID: 18307020